Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 257 record(s)

Req # A-2020-001590

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03343424.

Organization: Health Canada

10 page(s)
April 2021

Req # A-2020-001591

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03230625.

Organization: Health Canada

13 page(s)
April 2021

Req # A-2020-001592

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03346550.

Organization: Health Canada

10 page(s)
April 2021

Req # A-2020-001593

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03352275.

Organization: Health Canada

8 page(s)
April 2021

Req # A-2020-001594

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03232927.

Organization: Health Canada

10 page(s)
April 2021

Req # A-2020-001603

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03331704.

Organization: Health Canada

10 page(s)
April 2021

Req # A-2020-001677

Adverse Drug Reaction (ADR) for METRONIDAZOLE. Report number: E2B_01198405.

Organization: Health Canada

64 page(s)
April 2021

Req # A-2020-001763

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03473172.

Organization: Health Canada

15 page(s)
April 2021

Req # A-2021-000013

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_00476395.

Organization: Health Canada

15 page(s)
April 2021

Req # A-2019-000761

All internal Health Canada policies, directives, guidance, standard operating procedures, forms, checklists, job aids, and/or similar materials pertaining to the following topics: onboarding; new employee probationary period; performance management…

Organization: Health Canada

4763 page(s)
March 2021
Date modified: